A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association
Can Urol Assoc J. 2020 Jun;14(6):163-168.
doi: 10.5489/cuaj.6667.
1 The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
2 Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
3 Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
4 Department of Oncology, Division of Radiation Oncology, University of Alberta, Edmonton, AB, Canada.
5 Department of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
6 Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
7 Department of Oncology, Division of Radiation Oncology, McGill University, Montreal QC, Canada.
8 Division of Urology, Department of Surgery, Université Laval, Quebec City, QC, Canada.
9 Division of Urology, McMaster University, Hamilton, ON, Canada.
10 Division of Hematology and Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
11 Department of Radiation Oncology, CHUQ, Université Laval, Quebec City, QC, Canada.
12 Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
13 Department of Urology, Dalhousie University, Halifax, NS, Canada.